← Back to Search

Anxiety Skills Training for Anxiety

N/A
Recruiting
Led By Robyn L. Shepardson, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age >=18 years
Be older than 18 years old
Must not have
Current (past 2 weeks) severe depressive symptoms (>= 20 on PHQ9)
Diagnosis of Obsessive-Compulsive Disorder (OCD) or serious mental illness (SMI, i.e., psychotic disorders, bipolar disorder) in Problem List
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4 weeks, 8 weeks, 12 weeks, post-assessment (16 weeks), follow-up assessment (28 weeks)
Awards & highlights

Summary

This trial is testing whether a brief anxiety treatment is more effective at reducing anxiety symptoms and impairment in Veterans compared to usual care.

Who is the study for?
This trial is for Veterans aged 18 or older who have been seen at Syracuse or Western New York VA primary care clinics in the last year and are experiencing significant anxiety symptoms. It's not open to those with severe communication barriers, cognitive impairments that prevent informed consent, certain mental health diagnoses like OCD or SMI, current intensive psychotherapy for anxiety/depression, recent changes in psychotropic medications, severe depression, or PTSD.
What is being tested?
The study compares a brief behavioral treatment called Veterans Anxiety Skills Training (VAST), which includes up to six 30-minute sessions focused on cognitive-behavioral skills tailored for Veterans' needs against usual care. The effectiveness of VAST will be measured by looking at the severity of anxiety symptoms and functional impairment before and after treatment.
What are the potential side effects?
Since VAST is a non-medication intervention focusing on teaching coping skills for anxiety management rather than using drugs, it may not have typical drug side effects. However, discussing emotional topics during therapy could temporarily increase distress.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently experiencing severe depression.
Select...
I have been diagnosed with OCD or a serious mental illness.
Select...
I am able to understand and consent to the study on my own.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4 weeks, 8 weeks, 12 weeks, post-assessment (16 weeks), follow-up assessment (28 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4 weeks, 8 weeks, 12 weeks, post-assessment (16 weeks), follow-up assessment (28 weeks) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Overall Anxiety Severity and Impairment Scale change
Secondary study objectives
Depression Anxiety Stress Scale-21 change
Other study objectives
Columbia-Suicide Severity Rating Scale change
Quality of Life Enjoyment and Satisfaction Questionnaire-Short Form change
Sheehan Disability Scale change

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention conditionExperimental Treatment1 Intervention
Modular cognitive-behavioral anxiety intervention tailored to and personalized for Veterans
Group II: Control conditionActive Control1 Intervention
Usual care anxiety treatment

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,647 Previous Clinical Trials
3,359,900 Total Patients Enrolled
17 Trials studying Anxiety
1,886 Patients Enrolled for Anxiety
Robyn L. Shepardson, PhDPrincipal InvestigatorSyracuse VA Medical Center, Syracuse, NY
1 Previous Clinical Trials
35 Total Patients Enrolled
1 Trials studying Anxiety
35 Patients Enrolled for Anxiety

Media Library

Veterans Anxiety Skills Training Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04829240 — N/A
Anxiety Research Study Groups: Intervention condition, Control condition
Anxiety Clinical Trial 2023: Veterans Anxiety Skills Training Intervention Highlights & Side Effects. Trial Name: NCT04829240 — N/A
Veterans Anxiety Skills Training Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04829240 — N/A
~30 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top